Table 1.
Receptor | Transmembrane helix | Kd, nM | 95% confidence intervals | Bmax, pmol/mg | |
---|---|---|---|---|---|
Wild type | 2.1 | 1.70–2.40 | 18 ± 2.2 | ||
A76S | II | 1.2 | 0.92–1.39 | 12 ± 0.5 | |
A76L | II | 1.4 | 1.10–1.67 | 14 ± 0.4 | |
A76V | II | 1.4 | 1.00–1.28 | 9.1 ± 0.2 | |
A78S | II | 1.5 | 1.14–1.73 | 17 ± 1.1 | |
A78L | II | 0.9 | 0.47–1.39 | 9.0 ± 0.6 | |
A78V | II | 1.4 | 1.14–1.73 | 19 ± 0.4 | |
S120A | III | 2.3 | 1.77–2.96 | 28 ± 1.2 | |
S120L | III | 1.5 | 0.81–2.14 | 4.3 ± 0.3 | |
S120V | III | 1.6 | 0.58–2.62 | 4.9 ± 0.5 | |
A128S | III | 2.2 | 1.58–2.92 | 28 ± 1.4 | |
A128L | III | 3.2 | 1.00–5.39 | 4.8 ± 0.5 | |
A128V | III | 1.6 | 1.31–1.83 | 16 ± 0.5 | |
S161A | IV | 2.7 | 1.98–3.55 | 33 ± 2.0 | |
S161L | IV | ND | ND | ||
S161V* | IV | 2.0 | 0.80–3.14 | 2.7 ± 0.4 | |
S165A | IV | 4.7 | 3.54–5.98 | 15 ± 0.8 | |
S165L | IV | ND | ND | ||
S165V | IV | 1.2 | 0.68–1.71 | 6.7 ± 0.4 |
The values are expressed as the mean ± SE (n = 3–5 experiments). ND, not detected (no significant specific binding detected under the assay conditions).
*High nonspecific binding (15–20% of total binding).